Skip to main content

Research Repository

Advanced Search

Treatment and outcomes in breast cancer patients: A cross section study from the EUSOMA breast centre network

Aristei, Cynthia; Tomatis, Mariano; Ponti, Antonio; Marotti, Lorenza; Cardoso, Maria Joao; Cheung, Kwok Leung; Curigliano, Giuseppe; De Vries, Jakob; Santini, Donatella; Sardanelli, Francesco; Van Dam, Peter; Rubio, Isabel Teresa

Authors

Cynthia Aristei

Mariano Tomatis

Antonio Ponti

Lorenza Marotti

Maria Joao Cardoso

Giuseppe Curigliano

Jakob De Vries

Donatella Santini

Francesco Sardanelli

Peter Van Dam

Isabel Teresa Rubio



Abstract

Introduction
The present study was designed to describe tumour features and treatments for patients with breast cancer. It also aimed at assessing the risk of distant metastases in relation to biological profiles, disease stages and treatment.
Methods
Data were analysed from 81,882 patients in the EUSOMA database (disease stages at diagnosis 0-IV; median age 61 years; range 20–100 years). All patients were treated between January 2016 and December 2021 in 53 Breast Centres within the EUSOMA certification process in 13 European countries. Cases were classified as HR+ /HER2-, HR+ /HER2 + , HR-/HER2 + or HR-/HER2- and data were analysed accordingly.
Results
Univariable and multivariable analyses for distant metastases were conducted on a subset of 38,119 cases with information on whether or not they had developed them. Potential determinants included sub-group type, Ki67 value, disease stage, adjuvant systemic therapies and post-operative radiation therapy. In multivariable analysis, the HR-/HER2 + and HR-/HER2- sub-groups were associated with a higher risk of distant metastases than HR+ /HER2–. Ki67 > 20 % and advanced stage disease also carried a high risk. Radiation therapy emerged as a protective factor against distant metastases.
Conclusions
Present results show a large patient database offers an information stream that can be applied to reduce uncertainties in clinical practice. Database parameters need to be updated dynamically for outcome monitoring. Molecular prognostic factors, gene-expression signatures, tumour-infiltrating lymphocytes and circulating tumoral DNA should be added.

Citation

Aristei, C., Tomatis, M., Ponti, A., Marotti, L., Cardoso, M. J., Cheung, K. L., …Rubio, I. T. (2024). Treatment and outcomes in breast cancer patients: A cross section study from the EUSOMA breast centre network. European Journal of Cancer, 196, Article 113438. https://doi.org/10.1016/j.ejca.2023.113438

Journal Article Type Article
Acceptance Date Oct 30, 2023
Online Publication Date Nov 14, 2023
Publication Date 2024-01
Deposit Date Nov 30, 2023
Publicly Available Date Nov 15, 2024
Journal European Journal of Cancer
Print ISSN 0959-8049
Electronic ISSN 1879-0852
Publisher Elsevier
Peer Reviewed Peer Reviewed
Volume 196
Article Number 113438
DOI https://doi.org/10.1016/j.ejca.2023.113438
Keywords Breast cancer; Breast cancer treatments; Large database; Metastases; Risk factors; Protective factors
Public URL https://nottingham-repository.worktribe.com/output/27381089
Publisher URL https://www.ejcancer.com/article/S0959-8049(23)00740-2/fulltext
Related Public URLs https://www.sciencedirect.com/science/article/pii/S0959804923007402?via%3Dihub
PMID 37995597